InBody (인바디)
KOSDAQ · KRX: 041830
InBody is a South Korean biotechnology and health technology company that develops and manufactures body composition analysis devices and software solutions used in fitness, healthcare, and wellness settings worldwide. The company is listed on the KOSDAQ (Korea Securities Dealers Automated Quotations), South Korea's secondary stock exchange for growth and technology companies. InBody's core business involves the production of bioelectrical impedance analysis (BIA) equipment that measures body metrics such as muscle mass, body fat, and water content.
Filing timeline
highspotted 17:40 KST
InBody (KRX: 041830)- Cha In-jun (차인준), the reporting person, holds 3,922,333 shares representing 29.09% of InBody (인바디).
- Following an amendment to a share pledge agreement, Cha In-jun's controlled shares total 814,090 (6.04% of issued capital).
- No shares have been issued or allocated under derivative instruments (IRDs).
View original DART filing ↗AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.